These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 35841735)

  • 1. A waterfall of susceptibility results: impact of microbiology testing cascade for MDROs.
    Hernando K; Waite L; Bairagdar N; Manigaba K; Teelucksingh K; Dunn R; Casiano-Colon A
    Diagn Microbiol Infect Dis; 2022 Sep; 104(1):115731. PubMed ID: 35841735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Performance evaluation of VITEK 2 system in meropenem susceptibility testing of clinical Pseudomonas aeruginosa isolates].
    Acuner IC; Bayramoğlu G; Birinci A; Cekiç Cihan C; Bek Y; Durupınar B
    Mikrobiyol Bul; 2011 Jul; 45(3):411-21. PubMed ID: 21935774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Impact of antimicrobial stewardship program on antimicrobial usage and detection rate of multidrug-resistant gram-negative bacteria].
    Xu YL; Hu LM; Xie ZZ; Dong YW; Dong L
    Zhonghua Er Ke Za Zhi; 2019 Jul; 57(7):553-558. PubMed ID: 31269557
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of carbapenem restriction on the antimicrobial susceptibility pattern of Pseudomonas aeruginosa isolates in the ICU.
    Abdallah M; Badawi M; Amirah MF; Rasheed A; Mady AF; Alodat M; Alharthy A
    J Antimicrob Chemother; 2017 Nov; 72(11):3187-3190. PubMed ID: 28961733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective antibiotic susceptibility reporting and broad-spectrum intravenous antibiotic use: A multicentre ecological study.
    Smoke S; Raja K; Narayanan N; Brunetti L
    Int J Antimicrob Agents; 2019 Sep; 54(3):367-370. PubMed ID: 31202924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a carbapenem antimicrobial stewardship program and clinical outcomes in a Japanese hospital.
    Komatsu T; Inagaki R; Azuma S; Mochida S; Sato Y; Seto Y; Nihonyanagi S; Hoshiyama T; Wada T; Takayama Y; Atsuda K
    J Infect Chemother; 2022 Jul; 28(7):884-889. PubMed ID: 35331613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of computerized pre-authorization of broad spectrum antibiotics in Pseudomonas aeruginosa at a children's hospital in Japan.
    Horikoshi Y; Higuchi H; Suwa J; Isogai M; Shoji T; Ito K
    J Infect Chemother; 2016 Aug; 22(8):532-5. PubMed ID: 27263807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of a multimodal strategy combining a new standard of care and restriction of carbapenems, fluoroquinolones and cephalosporins on antibiotic consumption and resistance of Pseudomonas aeruginosa in a French intensive care unit.
    Abbara S; Pitsch A; Jochmans S; Hodjat K; Cherrier P; Monchi M; Vinsonneau C; Diamantis S
    Int J Antimicrob Agents; 2019 Apr; 53(4):416-422. PubMed ID: 30537533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementing carbapenem-resistance testing algorithms for Enterobacteriales and Pseudomonas aeruginosa: diagnostic and antimicrobial stewardship with timely infection prevention.
    Vega AD; Jimenez A; Rosello G; Claeys KC; Martinez OV; De Pascale B; Perez-Cardona A; Abbo L
    Diagn Microbiol Infect Dis; 2020 Aug; 97(4):115069. PubMed ID: 32559587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained pediatric antimicrobial stewardship program with consultation to infectious diseases reduced carbapenem resistance and infection-related mortality.
    Horikoshi Y; Suwa J; Higuchi H; Kaneko T; Furuichi M; Aizawa Y; Fukuoka K; Okazaki K; Ito K; Shoji T
    Int J Infect Dis; 2017 Nov; 64():69-73. PubMed ID: 28941633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbapenem stewardship: does ertapenem affect Pseudomonas susceptibility to other carbapenems? A review of the evidence.
    Nicolau DP; Carmeli Y; Crank CW; Goff DA; Graber CJ; Lima AL; Goldstein EJ
    Int J Antimicrob Agents; 2012 Jan; 39(1):11-5. PubMed ID: 22047702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbapenem stewardship with ertapenem and antimicrobial resistance-a scoping review.
    Zequinão T; Telles JP; Gasparetto J; Tuon FF
    Rev Soc Bras Med Trop; 2020; 53():e20200413. PubMed ID: 33174959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa).
    Tamma PD; Aitken SL; Bonomo RA; Mathers AJ; van Duin D; Clancy CJ
    Clin Infect Dis; 2021 Apr; 72(7):e169-e183. PubMed ID: 33106864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successfully controlling the incidence of multidrug-resistant Pseudomonas aeruginosa through antibiotic stewardship and infection control programmes at a Chinese university hospital.
    Li QY; Liu B; Liu L
    J Clin Pharm Ther; 2021 Oct; 46(5):1357-1366. PubMed ID: 34096086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacterial Epidemiology and Antimicrobial Resistance Profiles in Children Reported by the ISPED Program in China, 2016 to 2020.
    Fu P; Xu H; Jing C; Deng J; Wang H; Hua C; Chen Y; Chen X; Zhang T; Zhang H; Chen Y; Yang J; Lin A; Wang S; Cao Q; Wang X; Deng H; Cao S; Hao J; Gao W; Huang Y; Yu H; Wang C
    Microbiol Spectr; 2021 Dec; 9(3):e0028321. PubMed ID: 34730410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-World Performance of Susceptibility Testing for Ceftolozane/Tazobactam against Non-Carbapenemase-Producing Carbapenem-Resistant Pseudomonas aeruginosa.
    Rivas L; Alcalde-Rico M; Martínez JRW; Moreno MV; Rojas P; Wozniak A; García P; Olivares-Pacheco J; Miller WR; Arias CA; Khan A; Munita JM
    Antimicrob Agents Chemother; 2022 Jan; 66(1):e0165721. PubMed ID: 34780269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia.
    Perez KK; Olsen RJ; Musick WL; Cernoch PL; Davis JR; Peterson LE; Musser JM
    J Infect; 2014 Sep; 69(3):216-25. PubMed ID: 24841135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug-resistant Enterobacteriaceae, Pseudomonas aeruginosa, and vancomycin-resistant Enterococcus: Three major threats to hematopoietic stem cell transplant recipients.
    Satlin MJ; Walsh TJ
    Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28815897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of multidrug resistant organism acquisition in an adult specialist burns service: a retrospective review.
    Cleland H; Tracy LM; Padiglione A; Stewardson AJ
    Antimicrob Resist Infect Control; 2022 Jun; 11(1):82. PubMed ID: 35698209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa).
    Tamma PD; Aitken SL; Bonomo RA; Mathers AJ; van Duin D; Clancy CJ
    Clin Infect Dis; 2021 Apr; 72(7):1109-1116. PubMed ID: 33830222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.